Closed-Loop Glucose Control Using Multi-Model Predictive Dosing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current artificial pancreas systems lack effective control methods to manage abrupt and slow variations in glucose dynamics, relying on limited control algorithms that struggle with rapid changes and do not adequately account for insulin dynamics in the human body.

Innovation Solution

A closed-loop system incorporating a Multi-Model Predictive Controller (MMPC) algorithm that uses multiple state vectors and models to predict and adjust insulin delivery, integrating data from continuous glucose monitors and user input to optimize basal insulin deviation and glucagon dosing for improved glycemic control.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If conventional control algorithms are used in artificial pancreas systems, then the system structure remains simple, but the system cannot effectively handle abrupt and slow variations in glucose dynamics

Engineering Contradiction:
Improveadaptability to glucose dynamics variationsVSAvoidcontrol algorithm complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent implements a dynamic model of insulin action in the human body that adapts to both abrupt and slow variations in glucose dynamics. The controller continuously updates insulin sensitivity estimates and adjusts control parameters in real-time, transforming the static control algorithm into a dynamic system that responds to changing physiological conditions.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The control algorithm is segmented into multiple functional components: a glucose prediction module, an insulin action model, a control parameter optimization module, and a safety monitoring module. This segmentation allows each component to specialize in handling specific aspects of glucose dynamics, improving overall adaptability while maintaining manageable complexity through modular design.

Inventive Principle:
Principle #1Segmentation

2Adaptability or versatility

If a single fixed insulin model is used, then the control algorithm is simple to implement, but it cannot adequately control glucose concentrations when glucose dynamics are rapidly changing

Engineering Contradiction:
Improveresponse to rapid glucose changesVSAvoidinsulin model complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent replaces the static single fixed insulin model with a dynamic insulin action model that continuously adapts to changing glucose dynamics. The model estimates insulin sensitivity in real-time and adjusts its parameters based on observed glucose responses, enabling it to effectively control glucose concentrations during rapid changes while maintaining a computationally efficient structure.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The insulin model parameters are changed dynamically based on physiological conditions. The controller estimates insulin sensitivity as a time-varying parameter and adjusts the model parameters accordingly, allowing the same model structure to adapt to both rapid and slow glucose dynamics changes without requiring multiple complex models.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If non-adaptive controllers are used, then the control system is stable and easy to implement, but it is restricted to operating within a small range of variation

Engineering Contradiction:
Improveoperating rangeVSAvoidcontroller adaptability
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent transforms the non-adaptive controller into an adaptive system that continuously monitors glucose dynamics and adjusts control parameters accordingly. The controller estimates insulin sensitivity and other physiological parameters in real-time, expanding the operating range from a small fixed range to a broad adaptive range that covers various physiological states and glucose dynamics patterns.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The controller implements continuous feedback by monitoring glucose measurements and comparing them with predicted values. Based on the prediction errors and observed glucose responses, the controller updates its estimates of insulin sensitivity and adjusts control parameters, enabling operation across a wide range of variations while maintaining stability through controlled adaptation.

Inventive Principle:
Principle #23Feedback

Data Source

PatentEP3970611B1Closed loop control of physiological glucose
Publication Date: 2023.12.06 YPSOMED AG
  • EP3970611B1 patent drawingFigure 1
  • EP3970611B1 patent drawingFigure 1A
  • EP3970611B1 patent drawingFigure 2

AI summary

The present disclosure relates to a system to control glycemia in a patient. In one arrangement, the system comprises a user interface for inputting patient data including meal data. A controller receives the patient data, defines a state vector and an associated model, propagates the state vector, corrects the propagated state vector, determines a dose request based, at least in part, on the corrected-state vector, and transmits the dose request.